Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.
Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, ORTHOPRENEUR®, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.
- 8:30 a.m. Implanet was granted a U.S. patent protecting the JAZZ® technology platform through 2032.
- Bioretec's Activa implants, designed for fracture repair, arthrodesis, etc., reached the milestone of 100,000 patients operated over 10 years, with a complication rate of 0.01%.
- 11:30 a.m. Ferring Pharmaceuticals acquired exclusive development and commercialization rights to Seikagaku's SI-6603 injectable condoliase, a potential treatment for lumbar disc herniation, for up to US $95.0MM in upfront cash plus milestone payments.